National Observatory of New and Emerging Diseases, Tunis, Tunisia.
Laboratory of Medical Epidemiology, Pasteur Institute of Tunis, Tunis, Tunisia.
PLoS One. 2022 Mar 22;17(3):e0265390. doi: 10.1371/journal.pone.0265390. eCollection 2022.
The uptake and acceptance of the influenza vaccine (IV) among pregnant women remain unknown in Tunisia despite the increased influenza-related complications and death. The present study aimed to assess the IV uptake and acceptability and to describe related knowledge and attitudes among pregnant women in Tunisia.
A cross-sectional study was conducted in 84 Tunisian healthcare facilities over a period of three months (from March to May 2019). All pregnant women aged ≥18 years who sought antenatal care in related health structures were included in this study based on a multistage self-weighted sampling. We measured knowledge and attitudes towards the IV and assessed factors related to willingness for its uptake.
The questionnaire was completed by 1157 pregnant women. More than half of the participants (60.2%; 95% confidence interval [CI] [57.3%-63.0%]) reported awareness about the IV. Among included PW, only 4.6%; 95% CI [3.5%-6.1%] received it during their current pregnancy. However, (36.8%; 95% CI [34.0%-39.6%]) declared their willingness to receive the vaccine in the next pregnancy. Recommendation by healthcare providers, identified to be the most trustful source of information, was the main reason for acceptance. However, the intention to accept the IV by pregnant women was significantly associated with such recommendation and perceived safety and effectiveness of this vaccine.
Antenatal care visits are a precious opportunity that should not be missed by health care providers and especially gynecologists to promote the IV uptake by pregnant women in Tunisia.
尽管流感相关并发症和死亡增加,但突尼斯孕妇对流感疫苗(IV)的接种和接受程度仍不清楚。本研究旨在评估突尼斯孕妇对 IV 的接种率和可接受性,并描述相关知识和态度。
本横断面研究在三个月内(2019 年 3 月至 5 月)在 84 家突尼斯医疗保健机构进行。根据多阶段自我加权抽样,纳入所有在相关卫生结构中寻求产前保健的年龄≥18 岁的孕妇。我们测量了对 IV 的知识和态度,并评估了与接种意愿相关的因素。
1157 名孕妇完成了问卷。超过一半的参与者(60.2%;95%置信区间[CI] [57.3%-63.0%])报告说知道 IV。在包括的 PW 中,只有 4.6%;95%CI [3.5%-6.1%]在当前妊娠期间接种了疫苗。然而,(36.8%;95%CI [34.0%-39.6%])表示愿意在下一次妊娠中接种疫苗。被认为是最值得信赖的信息来源的医疗保健提供者的建议是接受疫苗的主要原因。然而,孕妇接受 IV 的意愿与这种建议以及对这种疫苗的安全性和有效性的看法显著相关。
产前保健就诊是一个不容错过的宝贵机会,医疗保健提供者,特别是妇科医生,应利用这一机会来促进突尼斯孕妇接种 IV。